Related Experiment Video
Updated: Aug 5, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Programmed cell death mechanisms of traditional plant medicine in prostate cancer therapy
Yuchen Zhang1,2,3,4, Sheng Qin4, Yingping Wang2,3
1Key Laboratory of Medicinal Materials, Jilin Academy of Chinese Medicine Sciences, Changchun, China.
Background:
Prostate cancer (PCa) is a prevalent malignancy in males with high morbidity and mortality. Although treatment modalities have evolved considerably, tumor resistance, recurrence, and metastasis persist, urgently requiring the exploration of alternative therapies for PCa. There is ongoing research on finding and identifying the use of traditional plant medicine (TPM). Cellular homeostasis comprises a sophisticated network of metabolic processes that functions cooperatively to preserve a stable intracellular environment. Programmed cell death (PCD) plays an important role in PCa mechanism. Thus, they represent an effective strategy for targeting PCa. TPM has been proven to induce PCD through multiple pathways and target in the treatment of PCa. Recent reviews have only focused on the one of the PCD, and autophagy, apoptosis, pyroptosis, ferroptosis, and necroptosis are not simultaneously reviewed.
Methods:
The search strategy: articles with the title containing "prostate cancer", "therapeutic", "traditional medicine", "apoptosis", "pyroptosis", autophagy", "in vivo/in vitro", "active ingredients", "Herbal", "real modules", "dose", "pathway", "effects/mechanisms", "extract", "pure compound", "drug type", "anticancer activity", "Chinese herbal compounds", "necroptosis" and "ferroptosis" had been initially selected in the past five years databases of PubMed, Web of Science, and ScienceDirect. The references were screened according to the strategy.
Results:
Forty-two drugs in the TPM have been chosen in this review. The plant extract, Chinese herbal compound, and pure compound of TPM exhibit significant anticancer activity against PCa by regulating multiple kinds of PCD. More importantly, PI3K/AKT/mTOR, AMPK/mTOR pathways, AKT1/Bcl2/NF-κB, GPBAR1/NF-κB, Keap1/Nrf2/ARE, PINK1/Parkin signaling pathways serve as critical molecular targets mediating the anticancer activities of TPMs in PCD. Autophagy, apoptosis, and ferroptosis are research hotspots, while pyroptosis and necroptosis are less explored. Apoptosis is co-detected with autophagy, or necroptosis. Ferroptosis is co-detected with necroptosis, or pyroptosis. Notably, the interrelationships between these cell death modes are rarely investigated in depth in the treatment of TPM in PCa. TPM has been induced apoptosis, ferroptosis, necroptosis in PCa. But the effect of TPM on the autophagy and pyroptosis need further evidence to clarify the mechanism.
Conclusion:
Hence, it is imperative to focus on elucidating the role of PCD modulators to refine therapeutic strategies of TPM in PCa.
Insights
Traditional plant medicine (TPM) shows promise in treating prostate cancer (PCa) by inducing various programmed cell death (PCD) pathways. Further research is needed to clarify mechanisms for autophagy and pyroptosis in PCa treatment.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Prostate cancer (PCa) remains a significant health concern with persistent challenges in treatment, necessitating novel therapeutic strategies.
- Traditional Plant Medicine (TPM) is being investigated as a potential alternative therapy for PCa due to its ability to induce programmed cell death (PCD).
- Existing reviews often focus on single PCD pathways, overlooking the simultaneous investigation of multiple PCD types like autophagy, apoptosis, pyroptosis, ferroptosis, and necroptosis in PCa.
Purpose of the Study:
- To comprehensively review the role of Traditional Plant Medicine (TPM) in inducing various programmed cell death (PCD) pathways for prostate cancer (PCa) treatment.
- To identify key molecular targets and signaling pathways involved in the anticancer effects of TPMs.
- To highlight research gaps concerning the interplay between different PCD modalities and TPMs in PCa therapy.
Main Methods:
- Systematic literature search across PubMed, Web of Science, and ScienceDirect databases for articles published within the last five years.
- Keywords included "prostate cancer," "therapeutic," "traditional medicine," various PCD types (apoptosis, pyroptosis, autophagy, necroptosis, ferroptosis), "active ingredients," "Herbal," and signaling pathways.
- Selection and screening of relevant articles based on the defined search strategy and inclusion criteria.
Main Results:
- Forty-two TPMs demonstrated significant anticancer activity against PCa by modulating multiple PCD pathways.
- Key molecular targets mediating TPM's anticancer effects include PI3K/AKT/mTOR, AMPK/mTOR, AKT1/Bcl2/NF-κB, GPBAR1/NF-κB, Keap1/Nrf2/ARE, and PINK1/Parkin signaling pathways.
- Apoptosis, autophagy, and ferroptosis are well-researched, while pyroptosis and necroptosis are less explored. Interactions between PCD types are rarely investigated in depth.
Conclusions:
- Traditional Plant Medicine (TPM) effectively targets prostate cancer (PCa) through the induction of apoptosis, ferroptosis, and necroptosis.
- The precise mechanisms of TPM-induced autophagy and pyroptosis in PCa require further investigation.
- Elucidating the role of PCD modulators is crucial for refining TPM-based therapeutic strategies for PCa.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Intrinsic Apoptotic Pathway
